Bayer AG (BAYNd)
FRA • Healthcare
May 22, 2026 at 17:30 UTC
About Bayer AG
Bayer AG is a life-science company that develops medicines and agricultural solutions and brings them to market under a single operating philosophy: rigorous science, reliable supply, and guidance that clinicians and growers can use in routine settings. Research feeds clinical and field programs, manufacturing turns validated methods into repeatable production, and local teams adapt access and stewardship to regional rules. The enterprise treats discovery and delivery as one chain, with safety and labeling woven into each step. Healthcare units focus on therapies used in everyday practice, while crop-related units support resilience on farms and in supply networks. Across regions, the aim is to make complex innovation feel workable: instructions that fit the day, inventories that show up, and data that closes the loop between use and improvement. In the healthcare and materials ecosystem, Bayer acts as a long-horizon partner to systems that cannot pause.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Bayer AG's Technical Indicators Summary
BAYNd presents a bullish tilt as the price trades above most short- and medium-term EMAs and comfortably above the 200-period average, signaling favorable positioning across timeframes. Momentum is constructive with a positive short-term momentum reading and RSI in the mid-50s, while MACD is near flat but not obstructive. Trend strength is modest, with ADX low, and volatility is moderate per ATR, which suggests orderly advance rather than erratic moves. On-balance volume is neutral, so conviction is present but not extreme. Technical takeaway: Bullish — multi-timeframe moving-average support underpins the positive technical bias.
| Indicator | Value |
|---|---|
RSI (14) | 56.35 |
Stochastic %K (14, 3, 3) | — |
CCI (20) | — |
WPR (14) | — |
Momentum (10) | 0.72 |
MFI | 46.73 |
MACD Level (12, 26) | -0.29 |
Bollinger Bands | — |
ATR (14) | $1.23 (3.14%) |
ADX (14) | 14.62 |
OBV | 80,406,613 |
Classic Pivot Point | $38.49 |
Fibonacci Pivot Point | $38.49 |
Simple Moving Averages | $37.94 - $37.94(5 indicators) |
Exponential Moving Averages | $34.59 - $38.99(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The session closed with mild sector strength (0.82%), slightly supporting risk appetite. Closing turnover for BAYNd remained on the soft side, running 0.32× typical levels. End-of-day, BAYNd still looked relatively defensive with a beta of 0.84.
Price Change
from €38.49 close
-€0.04
Trading Volume
Below avg (2.3M)
732.8K
vs S&P 500 Today
Underperforming Market
-0.87%
52-Week Position
Mid-range
56%
Updated: May 22, 2026 at 15:01 UTC
Quote Summary
BAYNd Headlines
Biotech, Pharma Stocks Draw Fresh Valuation Focus
April 2, 2026
Moderna, Mexico sign mRNA vaccine pact
February 11, 2026